Effect of Paracetamol, Dexketoprofen Trometamol, Lidocaine Spray, Pethidine and Diclofenac Sodium Application for Pain Relief During Fractional Curettage
Launched by KAYSERI EDUCATION AND RESEARCH HOSPITAL · Nov 20, 2013
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
A total of 144 mutiparous subjects randomly allocated one of six groups. The first group (control group) consisted of 22 participants and they did not receive any treatment. The second group consisted of 26 participants receiving oral 25 mg dexketoprofen trometamol. The third group consisted of 23 participants receiving 2 puff lidocaine sprays on cervical mucosa. The forth group consisted of 25 participants receiving 100 mg pethidine. The fifth group consisted of 23 participants receiving 1000 mg intravenous paracetamol and the sixth group consisted of 25 participants receiving diclofenac s...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • multiparous participants
- • abnormal uterine bleeding
- • postmenopausal bleeding
- • myoma uteri causing menometrorrhagia
- • cervical polyp
- • tamoxifen treatment for breast cancer
- • adnexial mass
- Exclusion Criteria:
- • abortions
- • pregnancy
- • primiparity
- • diabetes mellitus
- • tendency to bleed such as thrombocytopenia
- • factor deficiency
- • functional disorders of platelets
About Kayseri Education And Research Hospital
Kayseri Education and Research Hospital is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to improving health outcomes by facilitating rigorous scientific investigation in a wide range of medical disciplines. With a strong focus on collaboration and ethical practices, Kayseri Education and Research Hospital leverages its state-of-the-art facilities and multidisciplinary expertise to contribute to the development of new therapies and improve clinical standards. The hospital aims to enhance the quality of life for patients while fostering a culture of excellence in medical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kayseri, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials